Metastatic Colorectal Cancers Completed Phase 2 Trials for Selumetinib (DB11689)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00514761Phase II Efficacy Study of AZD6244 in Colorectal CancerTreatment